http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#Head http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#assertion http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#provenance http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#pubinfo http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#assertion http://purl.obolibrary.org/obo/DOID_594 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_594 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00404 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association http://www.w3.org/2000/01/rdf-schema#label alprazolam tablets are indicated for the management of anxiety disorder a condition corresponding most closely to the apa diagnostic and statistical manual dsm iii r diagnosis of generalized anxiety disorder or the short term relief of symptoms of anxiety anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry apprehensive expectation about two or more life circumstances for a period of six months or longer during which the person has been bothered more days than not by these concerns at least 6 of the following 18 symptoms are often present in these patients trembling twitching or feeling shaky muscle tension aches or soreness restlessness easy fatigability shortness of breath or smothering sensations palpitations or accelerated heart rate sweating or cold clammy hands dry mouth dizziness or light headedness nausea diarrhea or other abdominal distress flushes or chills frequent urination trouble swallowing or lump in throat feeling keyed up or on edge exaggerated startle response difficulty concentrating or mind going blank because of anxiety trouble falling or staying asleep irritability these symptoms must not be secondary to another psychiatric disorder or caused by some organic factor motor tension autonomic hyperactivity vigilance and scanning anxiety associated with depression is responsive to alprazolam alprazolam tablets are also indicated for the treatment of panic disorder with or without agoraphobia studies supporting this claim were conducted in patients whose diagnoses corresponded closely to the dsm iii r criteria for panic disorder see clinical studies panic disorder is an illness characterized by recurrent panic attacks the panic attacks at least initially are unexpected later in the course of this disturbance certain situations eg driving a car or being in a crowded place may become associated with having a panic attack these panic attacks are not triggered by situations in which the person is the focus of others attention as in social phobia the diagnosis requires four such attacks within a four week period or one or more attacks followed by at least a month of persistent fear of having another attack the panic attacks must be characterized by at least four of the following symptoms dyspnea or smothering sensations dizziness unsteady feelings or faintness palpitations or tachycardia trembling or shaking sweating choking nausea or abdominal distress depersonalization or derealization paresthesias hot flashes or chills chest pain or discomfort fear of dying fear of going crazy or of doing something uncontrolled at least some of the panic attack symptoms must develop suddenly and the panic attack symptoms must not be attributed to some know organic factors panic disorder is frequently associated with some symptoms of agoraphobia demonstrations of the effectiveness of alprazolam by systematic clinical study are limited to four months duration for anxiety disorder and four to ten weeks duration for panic disorder however patients with panic disorder have been treated on an open basis for up to eight months without apparent loss of benefit the physician should periodically reassess the usefulness of the drug for the individual patient http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00404 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#provenance http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#pubinfo http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#sig http://purl.org/nanopub/x/hasSignature FR33Su08cyPAcfmuoDgNu4vOwpJmnGVI57VTkGa/PRh2pKHoz0U9IRXL3B5XLqtc7YK6YRs0Neb5FkIfoCIi6XOZCZYoJpJFQ02h/qx5BN9kVHMvJpjVWjQRJSqaJ7nLP7AGPdyfWcucFQAJ498Om8l2ShdaEarFBHSWPR+sd20= http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://purl.org/dc/terms/created 2021-07-03T14:17:16.812+02:00 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAKXC8nu5o_IY2KyjqkGeOdFaq3Q3et_Hm87sHX6Zh8a4 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs